機器人(300024.SZ):加速半導體裝備業務板塊的快速擴張
格隆匯6月2日丨機器人(300024.SZ)於2023年6月1日14:30-16:30參與“走進上市公司”投資者開放日活動,互動環節中,就“公司對半導體板塊的發展構想?”,公司回覆稱,在國內半導體設備國產替代的迫切需求下,2023年半導體產業鏈的國產化在深入推進。公司將繼續加大半導體裝備的研發投入,對標國際競爭對手的主流產品,加速推進產品導入和批產工作,提前為業務拓展進行產能佈局。今年公司已設立全資子公司以發展和運營半導體裝備業務,致力於抓住國產化浪潮的市場機遇,加速半導體裝備業務板塊的快速擴張。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.